Attachments
This epidemiological bulletin aims to provide the situation of key infectious diseases in the WHO South-East Asia Region to inform risk assessments and responses. The bulletin uses information from publicly available sources and will be published every two weeks. For feedback or suggestions, please write to seoutbreak@who.int.
Cox’s Bazar/Bangladesh: Acute Watery Diarrhea/Cholera
Situation as of 12 January 2025
- The Directorate General of Health Services (DGHS), supported by the Global Task Force on Cholera Control (GTFCC), the World Health Organization (WHO), the International Centre for Diarrheal Disease Research, Bangladesh (icddr,b), and partners, has launched a reactive Oral Cholera Vaccination (OCV) campaign in Cox’s Bazar.
- The campaign targeted both Rohingya refugee camps and host communities and runs until 21 January 2025.
- Over 450 cholera cases have been reported in the past six months, with 92% from Rohingya refugee camps.
- The DGHS received 1.6 million OCV doses from the International Coordinating Group (ICG).
- The vaccination uses Euvichol and Euvichol-Plus vaccines, covering camps and host areas.
- A house-to-house vaccination strategy is employed, using Controlled Temperature Chain (CTC) technology for vaccine storage.
- Collaboration with local health authorities and partners ensures comprehensive coverage.
- The initiative builds on the success of the 2017 pre-emptive cholera vaccination campaign.